Fariba Navid

7PUBLICATIONS
41CO-AUTHORS
OrthopticsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)Child and adolescent development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 03, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.

Srivandana Akshintala, R Taylor Sundby, Donna Bernstein

|Feb 22, 2023
Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors.

Eirini Christodoulou, Venkata Yellapantula, Katrina O'Halloran

|Jul 28, 2022
The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors.

David P Douglass, Fariba Navid, Aaron R Weiss

|Jun 21, 2017
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy.

Fariba Navid, Victor M Santana, Michael Neel

Pageof 2